Press "Enter" to skip to content

Amgen Adds Celgene’s Otezla to Bolster Pipeline at Pricey Valuation – TheStreet.com

admin 0

Amgen Adds Celgene’s Otezla to Bolster Pipeline at Pricey Valuation  TheStreet.com

Amgen Inc. (AMGN) is adding to its stable of profitable drugs with the announcement that it will acquire the global rights to Celgene Corp.’s (CELG) oral psoriasis …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *